Melinta Therapeutics
Melinta Therapeutics Enters Into Agreement to Acquire Infectious Disease Business from The Medicines Company
29. November 2017 07:00 ET | Melinta Therapeutics
- Acquisition positions Melinta as durable and focused pure-play antibiotics company with four marketed products: Baxdela®, Vabomere®, Orbactiv®, and Minocin IV® - - Peak sales potential of the...